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Abstract 
Angiogenesis, the growth of new blood vessels from pre-existing vessels, is a critical process for 
proper embryonic development. BMPs (bone morphogenetic proteins) are key angiogenic 
players that are highly expressed during lung development, but the role of these proteins in the 
context of lung angiogenesis is not well characterized.  A previous study showed that over-
expressing Matrix Gla protein, an upstream BMP inhibitor, decreased lung vasculature. 
Importantly, our lab has also shown that overexpression of bmp2b, a BMP ligand, induces 
ectopic vessel sprouting in developing zebrafish. Additionally, endothelial-specific deletion of 
BMP receptor II (BMPR2) leads to decreased vascular sprouting in the postnatal mouse retina. 
Taken together, this evidence suggests that modulations in BMP signaling lead to perturbations 
in vessel development and sprouting. Therefore, I predict that deletion of BMPR2 in the 
endothelium during lung development will result in decreased angiogenesis when compared to 
control lungs. Preliminary results show that there is a steady increase in blood vessel branching 
from E (embryonic day) 10.5 to E12.5 of mouse development in the lung buds, and that genetic 
deletion of BMPR2 in endothelial cells reduces vessel branching in embryonic lungs. 
  
Introduction 
The establishment of a vascular network is a crucial process in the developing embryo. 
The earliest vascular development occurs de novo via differentiation of angioblasts into 
endothelial cells that then fuse to form larger vessel networks in a process called vasculogenesis 
(Baldwin et al.,1996). Distinct from vasculogenesis, angiogenesis, the process by which new 
blood vessels form from pre-existing vessels by sprouting of endothelial cells from a parent 
vessel, is an especially vital process by which oxygen and nutrient delivery to organs is 
maintained throughout development. These processes occur simultaneously and collaborate 
during lung vascular development.  Angiogenesis occurs centrally in the lung forming the axial 
and lateral arteries and veins while vasculogenesis occurs distally in the periphery, forming 
isolated blood lakes that fuse with the central branches (de Mello et al., 1997). In later stages of 
gestation, these vessels remodel into a network of more uniform vessels.  
During angiogenesis, the existing vessels receive cues, which induce sprouting and 
branching, and ultimately, lead to formation of new vessels. Several signaling pathways have 
been implicated in inducing angiogenesis, including VEGF and BMP. Although the effects of 
VEGF signaling on vessel sprouting, branching, and maintenance have been extensively studied, 
the function of BMP as a regulator of angiogenesis has not been characterized to the same extent 
(Kushner and Bautch, 2013). The BMP pathway is activated when BMP ligands dimerize and 
interact with BMP Type II and Type I receptors on target tissues. This signal is transduced via 
the cytoplasmic SMAD family of proteins. Knock-out and over-expression manipulations in the 
players of the BMP pathway have resulted in striking effects on angiogenesis. For example, the 
overexpression of bmp2b ligand via a heat shock promoter leads to ectopic sprouting from the 
cardinal vein in the zebrafish during development (Wiley et al., Nature Cell Bio, 2011). Mutating 
endofin, a negative regulator of the BMP pathway, in osteoblasts increased vascular density in 
long bones (Zhang et al., 2009). Further studies in our lab, in which the BMP type II receptor, 
BMPR2, was deleted in endothelial cells of the post-natal mouse retina, resulted in decreased 
sprouting at the vascular front and decreased branching in the vessel plexus behind the vascular 
front (Chong, unpublished). This evidence suggests that BMP signaling is pro-angiogenic, such 
that increased BMP signaling leads to increased branching whereas decreased BMP signaling 
reduces branching and sprouting angiogenesis.  
In lungs, BMPs are closely associated with branching morphogenesis of the lung 
epithelium. BMPs are expressed in intricate and stereotyped patterns in the developing lung 
(Danesh et al., 2009). As the primitive lung buds begin to develop off the primordial gut tube 
around embryonic day (E) 9.5, distinct BMP4 patterning is detected (Weaver et al., 
Development, 1999). This expression of BMP4 is dynamic throughout the stages of lung 
development from E10.5 to E17.5 and tends to localize in the endoderm at the tips of the 
growing buds starting from E11.5 (Bullusci et al., 1996). Despite the many studies of how BMP 
expression and signaling regulates lung budding and branching morphogenesis, its function as a 
regulator of lung vascular development has been less studied.  Upstream regulators of the BMP 
pathway are implicated in vascular development of the lung, although the effects of direct 
manipulations to the BMP signaling pathway have not been analyzed in this organ. The deletion 
of matrix gla protein, an upstream negative regulator of BMP, leads to increased branching in 
lung vasculature (Yao et al., 2011). This suggests that BMP signaling is pro-angiogenic in the 
lung.   
To investigate the role of BMP signaling on angiogenesis in the developing lung, we 
have analyzed branching parameters in wild-type lungs expressing an endogenous vascular 
marker during different embryonic stages (E10.5-E12.5) of lung development. We showed, 
through this initial characterization, a trend in which branching increases steadily over this 
period. By genetically deleting BMPR2 in the endothelium using the Cre-Lox system, we are 
discovering the effects of decreased BMP signaling on the developing vasculature of the lung. 
Preliminary results in E11.5 lungs suggest decreased branching as a result of BMPR2 deletion in 
endothelial cells. We are currently solidifying and expanding the characterization of E11.5 lungs 
with BMPR2 deletion.  
 
Materials and Methods 
Animals. Wild-type embryos were generated from matings between Flk1-GFP and CD-1 albino 
mice. This produced embryos containing an endothelial cell-specific Flk1 promoter driving 
expression of green fluorescent protein (GFP) for facilitated visualization of vessels.  These 
embryos were collected on gestational stages E10.5, E11.5, E12.0, and E12.5, counting the 
morning of the vaginal plug as E0.5. We dissected the embryos in PBS and fixed in 4% 
paraformaldehyde (PFA) for 1 hour. The embryos were then washed three times with PBS in 
five-minute intervals. Embryos that were GFP-positive were separated from GFP-negative. The 
lungs were dissected from embryos in PBS and kept in PBS at 40C until sectioned or mounted 
for analysis.  
Mutant embryos were generated by mating a Flk1-GFP; Cdh5-CreERT2; Bmpr2flox/flox male to a 
Bmprflox/flox; Rosa-tdTomato females in order to create a line of embryos with Flk1-GFP; Cdh5-
CreER; Bmpr2flox/flox; Rosa-tdTomato. Cdh5-CreER is a transgenic line which expresses the 
tamoxifen-dependent Cre-ER recombinase under the Cdh5 promotor, an endothelial-specific 
promoter (Sorenson et al., 2009). Two days prior to the harvest date, 3mg of tamoxifen was 
injected intraperitoneally. The administration of tamoxifen activates the Cre-recombinase and 
excises the loxP flanked exons four through five of the Bmpr2 locus (Beppu et al., 2005). To 
determine Cre-excision efficiency, we included a Rosa-tdTomato reporter in the same line of 
embryos. The Rosa-tdTomato reporter contains a lox-STOP-lox cassete with a downstream 
tdTomato gene inserted in the Rosa26 endogenous locus (Madison et al., 2010). Therefore, when 
tamoxifen is administered, the STOP codon is also excised and the downstream tdTomato 
reporter protein, a red fluorescent protein, is expressed. The outcome is an embryo in which 
BMPR2 deleted in endothelial cells (BMPRiECKO) expresses ROSA-tdTomato to aid in 
determining excision efficiency. We estimated and confirmed BMPR2 deletion in endothelial 
cells via the co-localization of ROSA-tdTomato reporter (red-fluorescent protein) and the 
FLK:GFP expressed under the vessel-specific, Flk1 promoter.  The embryos were dissected and 
a small piece of the limb or tail was collected for genotyping. The embryos were fixed in 4% 
PFA individually in tubes for 1 hour. Then, they were washed three times with PBS in five-
minute intervals.  
Genotyping.  The Viagen Direct-PCR lysing system was used to lyse the samples collected from 
the embryos. After lysing, PCR reactions were performed using 2X PCR Master Mix (Thermo 
Scientific). The following primers were used to detect BMPR2 flox: 5’ TTA TTG TAA GTA 
CAC TGTT TGC TGT C 3’, 5’GGC AGA CTC TGA CTT TGA CGC TAG 3’. A flox band is  
315 bp and a WT band is 260 bp. To detect Cdh5CreER mutants we used primers 5’GAC CAG 
CTT CGT TCA CTC A3’, 5’TAG CGC CGT AAA TCA AT 3’. The Cdh5 Cre ER mutants 
produce a 500 bp band. Flk1-GFP was genotyped by examining positive GFP fluorescence under 
an epifluorescent microscope.  
Vibratome Sectioning. The lungs were embedded in 4% low melting agarose and sectioned into 
250-micrometer slices using a Leica VT1200S Vibratome. The surface sections were kept and 
mounted with Vectashield to reduce variability between sections.  
Whole Mount. The lungs were embedded in 1% low melt agarose on a Matek dish. The Matek 
dish was filled with 4% low melt agarose to stabilize the area surrounding the lung. The sample 
was covered with PBS to prevent drying in the dish before imaging.  
Imaging. An FV-1200 Olympus confocal microscope with 40x silicon-oil immersion objective 
was used to image vibratome sections. Imaging was done both in the XY plane and in the Z 
plane. The step size used for Z-plane imaging ranged from 3-5 microns and the number of Z 
planes imaged ranged from 28-36. The multi-area acquisition tool was used to image large 
regions of the lung and the stitch tool was used to stitch these regions together to obtain one 
image of the complete lung. An Olympus two-photon microscope with 25x gel immersion 
objective was used to image the whole-mounted lungs. The Z-step size used was 1.0 um and 
150-200 planes were imaged. 
Analysis. The images of the lungs were compressed along the Z plane at max intensity using 
ImageJ. Vessels were traced in Adobe Photoshop. In cases of discrepancies between vessel 
connections, the uncompressed Z-stacks were consulted. If the vessels structures could not 
clearly be deciphered as was the case near the tips of the lung buds due to low GFP expression, 
then these regions of vessels were not traced. These tracings were re-opened on ImageJ and the 
“skeletonize” and “analyze skeletonize” tools were used to obtain branching data. Imaris 
software is currently be used to create 3-D surfaces and reconstructions of the vasculature of the 
lung. We plan to use the “filament tracing” tool in Imaris to analyze branching using the 3-D 
reconstructions of the lung vasculature.  
Statistics. Both one-way ANOVA and student-t tests were used to determine statistical 
significance in sectioned wild-type lungs using Prism. Unpaired student t-tests were performed 
on every combination of two-stages of sectioned wild-type lungs. Unpaired student t-tests were 
performed on whole-mount sectioned lungs to determine statistical significance between E10.5 
and E11.5. Unpaired student t-tests were also performed to determine statistical significance 
between sectioned and whole-mount E11.5 WT and mutant lungs. In all cases, significance was 
set at p≤ 0.05 
Results 
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Figure 1. Branching increases in sectioned wild-type lungs as developmental stage increases. 
(A-D) representative images of vibratome sections from stages E10.5, E11.5, E12.0, and E12.5, 
respectively. Yellow outline indicates individual lung buds in the image. Scale bars denote 100 
micrometers. (E) Graph with quantified branches/mm by embryonic stage. Asterisks denote 
significance p≤0.05 as determined by an unpaired student t-test.  
 
 
Figure 2. Branching increases in whole-mounted wild-type lungs as developmental stage 
increases. (A,B) representative images of E10.5 and E11.5 whole-mounted lungs, respectively. 
Scale bars denote 100 micrometers. (C) branching in whole mounted E10.5 and E11.5 lungs. 
Left bud (L), right caudal bud (RCd), right medial bud (RMd), right cranial bud (RCr). Right 
medial buds at E11.5 were not quantified.  
 
  
 
Figure 3. Branching decreases when BMPR2 is excised in endothelial cells in sectioned lungs. 
(A) representative image of sectioned wild-type lung (B) representative image of sectioned 
BMPR2iECKO lung. Scale bars denote 100 micrometers. (C) branching in sectioned WT vs 
BMPR2 iECKO E11.5 lungs. 
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Figure 4. Branching decreases when BMPR2 is excised in endothelial cells in whole mount 
lungs. (A) representative image of whole mount lung (B) representative image of whole mount 
BMPR2iECKO lung. Scale bars denote 100 micrometers. (C) branching in whole mount WT vs 
BMPR2 iECKO E11.5 lungs.  
 
Branching increases in sectioned wild-type lungs as developmental stage increases. 
To characterize wild-type angiogenesis throughout the embryonic phase of lung development, 
we utilized Flk1-GFP mice to visualize vessels. Flk1-GFP mice have GFP inserted into the Flk1 
locus such that green fluorescent protein is expressed via the Flk1 promotor, which is selective 
for endothelial cells of developing blood vessels (Ema et al., Blood, 2006). We quantified 
branching from individual lung buds in sectioned lungs by tracing vessels at stages E10.5, E11.5, 
E12.0, and E12.5 (Figure 1A-D). The number of branch points was normalized to the total length 
of the vessels. The number of branches/mm for embryonic stages E10.5, E11.5, E12.0, and E12.5 
were 25.9±2.9, 26.0±3.3, 33.0±3.7, and 37.8±0.5 branches/mm, respectively (Figure 1E).  There 
was no statistical significance between the groups using one-way ANOVA, however, as 
expected, the trend of the data demonstrates that as the stage of the lungs increase, there is an 
 WT  BMPR2
iECKO
 
E1
1.
5 
W
h
o
le
 M
o
u
n
t 
A B C 
increase in branching. Furthermore, using a student t-test, we found statistical significance in 
branching between E10.5 and E12.5 with a p value of 0.01 and between E11.5 and E12.5 with a 
p-value of 0.03 (Figure 1E).  Overall, this data shows that branching of vessels increases during 
lung development and our method for branching calculations are reliable and reproducible.  
 
Branching increases in whole mount wild-type lungs as developmental stage increases. 
To determine if this trend of increased branching could also be detected in whole mount wild-
type lungs, we embedded E10.5 and E11.5 lungs as whole mounts in agarose and utilized a two-
photon microscope to capture vessels at a greater depth (Figure 2A, B). We traced vessels and 
analyzed branching in the same manner as the sections were quantified, by normalizing the 
number of branch points to the total length of vessels in millimeters. We found that E10.5 and 
E11.5 lungs had 30.4±2.3 branches/mm and 35.5±0.8 branches/mm, respectively (Figure 2C). 
Again, we saw that branching increased during lung development, although there was no 
statistical significance between these two stages as determined by a student t-test (Figure 2C). In 
both E10.5 and E11.5 stages, the whole mount had more branching than the sections, suggesting 
that this method captures more branching than sectioning and using confocal microscopy.  
 
Endothelial cell genetic deletion of BMPR2 decreases branching in embryonic lung 
sections. 
Once we quantified branching in wild type lungs and established reliable methods for 
quantifying vessel branching, we explored the effects of endothelial cell-specific genetic deletion 
of the BMP receptor, BMPR2, on blood vessel branching in the developing mouse lung. We 
mated a Cdh5-CreER; Bmprflox/flox; Flk-eGFP male with a Bmprflox/flox; Rosa tom/tom female to 
generate an embryo in which Bmpr2 in endothelial cells could be excised by a tamoxifen-
dependent Cre-ER recombinase and also expressed the vessel-specific marker FLK1:GFP (see 
Methods). We induced Cre-ER recombinase with tamoxifen, such that our embryos had 
genetically deleted Bmpr2 in endothelial cells starting at E9.5.  We dissected the lungs at E11.5. 
Using the co-localization of Rosa-tdTomato reporter (see Methods) and FLK:GFP, we estimated 
that Cre-mediated excision ranged from 30-60% of endothelial cells in the imaged mutant lungs. 
Despite incomplete excision of Bmpr2, we saw reduced vessel branching in lungs of embryos 
that also had the Cre-driver transgene. The mutant lungs at E11.5 had 23.2±3.0 branches/mm, 
which was on average approximately 5 branches less than the wild-type E11.5 lungs, which had 
28.0±3.4 branches/mm. This difference is currently not statistically significant, however, the lack 
of significance can be attributed to the low cre-excision efficiency and our low sample size. 
Through future experiments, we are planning to expand our sample size and increase excision of 
BMPR2 in endothelial cells in our mutant lungs. 
 
Endothelial cell genetic deletion of BMPR2 decreases branching in embryonic lung whole-
mount. 
Because we found that lungs embedded in whole-mount allowed us to measure more branching, 
we used whole-mount lungs to determine the effects of genetic deletion of BMPR2 in endothelial 
cells on lung vessel branching at E11.5. We confirmed that the whole mount analysis yielded 
overall increased branching numbers when compared to wild type. The mutant whole mounted 
embryonic lungs at E11.5 had 32.5±2.1 branches/mm compared to 35.5±0.8 branches/mm. This 
difference is not currently statistically significant. The whole mounted lungs were from the same 
experiment as for the BMPR2 genetic deletion analysis performed for the sectioned lungs and 
thus, Cre-excision efficiency and our low sample size is also a caveat for this experiment. 
However, overall trends show that there is decreased branching in BMPR2 iECKO lungs when 
compared to wild-type embryonic mouse lungs. 
 
 Discussion  
Although BMPs have been implicated in vessel sprouting and branching, the role of 
BMPs in early vessel patterning during lung development has not been well characterized. 
We hypothesized that decreased BMP signaling would lead to decreased angiogenesis in the 
developing lung. In this study we analyzed lungs throughout the embryonic phase of 
development, E9.5 to E12.5, for evidence of blood vessel branching. We demonstrate that 
branching of vessels in wild-type lungs increases from stages E10.5 to E12.5. Preliminary 
experiments with BMPR2iECKO at E11.5 stages show that, compared to the wild-type, there is a 
decrease in branching, suggesting the BMP signaling is involved in regulating angiogenesis in 
the lung. To date, this data is not statistically significant, however, the trend of the data supports 
our hypothesis and corroborates with previous studies that suggest that BMP is a pro-angiogenic 
cue. 
To characterize angiogenesis throughout the embryonic phase of lung development, we 
quantified branching of vessels. Although we saw some evidence of sprouting, the abundance of 
sprouting was significantly less than other classical in vivo angiogenesis models, such as the 
postnatal mouse retinal model. These were not the only differences we noted between lung 
vessels and these other sprouting models. When we first started imaging lung vessels, we 
observed a striking difference in the morphology of the lungs vessels from other mouse retinal or 
zebrafish sprouting models. For example, most vessels in the zebrafish and the mouse retina are 
uniform and characterized largely by sprouting angiogenesis. In contrast, our lung vessels looked 
irregular and variable in size with small holes or divots. Previous studies of the microvasculature 
in post-natal rat lungs corroborate this characterization of lung vessels and demonstrated that the 
primary mechanism of angiogenesis in the lung takes the form of intussusceptive, non-sprouting, 
vessel proliferation (Caduff et al., 1986). This process of intussesceptive angiogenesis in which 
perforations or holes in the vessels creates new vessels is not as well-understood as sprouting 
angiogenesis (Risau et al., 1997). Given the lack of sprouting angiogenesis and similar 
observations of “tiny holes” in the vessels of our embryonic lungs, this suggests that 
intussesceptive angiogenesis is also the primary mechanism of lung vessel development during 
mouse embryonic development.   
 The process of branching may be driven by BMP-induced manipulations on endothelial 
cell migration and/or proliferation in lung vessels.  Previous studies have implicated BMPs in 
endothelial cell migration and proliferation in vivo. BMP-4,-6,-9 for example, induced 
proliferation of mouse embryonic-stem-cell-derived endothelial cells when exogenously added in 
culture (Suzuki et al., 2010).  BMPs also have demonstrated effects on migration. When BMP-4 
was added to these cells, there was also an increase in random migration over a 24 hour period 
(Suzuki et al., 2008). This provides one explanation by which BMP signaling may be involved in 
regulating angiogenesis during development.  
Although BMPs have demonstrated effects on endothelial cell migration and proliferation, 
this mechanism may not wholly describe the course by which angiogenesis in the embryonic lung 
is occurring, especially if intussusceptive angiogenesis characterizes lung vascular development. 
Intussusceptive angiogenesis is not thought to be as highly dependent on endothelial cell 
proliferation and migration compared to sprouting angiogenesis (Burri et al., 2004). Therefore 
effects on branching in the lung may suggest that BMPs have undiscovered effects on transluminal 
tissue pillar formation, a hallmark of intussusceptive angiogenesis that affects vessel branching in 
lungs (Djonov et al., 2000). One experiment by which we can probe the migration and proliferative 
capabilities of endothelial cells in the embryonic lung is to embed ex-vivo wild-type and 
BMPR2iECKO lungs in a matrix and quantify migration and sprouting of labeled endothelial cells. 
This will help determine whether BMP also plays a role in migration and proliferation of lung 
endothelial cells during development.   
We also consistently noted that in E10.5 and in some E11.5 lungs, the tips of the lung 
buds had low GFP expression. At first, we suspected that GFP expression was being quenched 
during the process of imaging. However, this GFP expression remained consistent even when 
protocols were amended so that imaging was performed sooner after dissection. This observation 
suggests that vasculogenesis is still actively occurring at distal ends and angiogenesis is the not 
the sole process by which the embryonic lung vasculature develops (Parera, 2005). We suspect 
that the low, irregular GFP expression is indicative of angioblasts that are actively differentiating 
into endothelial cells. As of yet, we have not performed BMPR2 deletion experiments on E10.5, 
where this pattern of GFP expression has been most prevalent. However, BMPs also have 
demonstrated effects on endothelial cell differentiation. In a previous study human embryonic 
stem cells (hSECs) cultured with high-dosage treatment of exogenous BMP lead to an increase in 
hSECs committed to the endothelial cell lineage. This same study also noted a higher rate in 
endothelial cell differentiation (Goldman et al., 2009). This suggests that a decrease in BMP 
signaling would also decrease vasculogenesis at the periphery in the early stages where 
angioblasts are differentiating into endothelial cells. We plan to further characterize branching of 
BMPR2iECKO lungs at E11.5 and to expand this characterization in other stages moving forward. 
 Importantly, studies on the effect of endothelial cell BMPR2 deletion on branching has 
relevancy for disease. Pulmonary arterial hypertension (PAH) is a disease characterized by 
defective remodeling of peripheral blood vessels in the lung. Heterozygous germline mutations in 
BMPR2 are highly correlated with pulmonary arterial hypertension (Cai et al., 2012). It would be 
interesting to see if PAH lungs have perturbed or dampened branching as has been suggested from 
our BMPR2 deletion experiments. In any case, elucidating the role of BMP signaling during lung 
development will aid in unraveling the complexities of this pathway as well as provide therapeutic 
benefits for diseases in which vessels are abnormal due to BMP signaling. 
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